Not Medicare Enrolled

Dr. Odette Campbell, M.D.

Internal Medicine · Plano, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
5072 W PLANO PKWY STE 220, Plano, TX 75093
4696710900
In practice since 2006 (20 years)
NPI: 1114989092 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Campbell from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Campbell? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Campbell

Dr. Odette Campbell is an internal medicine specialist in Plano, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Campbell performed 19,762 Medicare services across 8,758 unique beneficiaries.

Between the years covered by Open Payments, Dr. Campbell received a total of $200 from 7 pharmaceutical and/or device companies across 7 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Campbell is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 2% volume in TX $200 industry payments

Medicare Practice Summary

Medicare Utilization ↗
19,762
Medicare services
Top 2% in TX for internal medicine
8,758
Unique beneficiaries
$101
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~988 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Drug screening test 4,095 $61 $65
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms 4,071 $242 $325
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a 2,080 $29 $60
Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow 1,560 $75 $110
Remote patient monitoring management, 20 min/month 556 $37 $80
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional 516 $18 $41
Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes 488 $140 $199
Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes 473 $31 $76
Home visit, established patient, moderate complexity 437 $98 $141
Remote patient monitoring device, 30 days 431 $37 $80
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and 401 $40 $60
Measurement of brain wave activity (eeg), digital analysis 381 $174 $244
Evaluation of neuropsychological test, first hour 372 $97 $219
Administration of psychological or neuropsychological test by technician, each additional 30 minutes 354 $26 $94
Administration of psychological or neuropsychological test by technician, first 30 minutes 352 $25 $54
Measurement of brain wave activity (eeg), awake and drowsy 349 $277 $442
Electrocardiogram (ecg) 1 to 3 leads with review by physician 346 $10 $20
Office visit, established patient (30-39 min) 294 $70 $118
Test to measure expiratory airflow and volume changes before and after medication administration 281 $28 $69
Ultrasound study of arm and leg arteries 252 $57 $78
Test for balance and posture 219 $35 $85
Annual wellness visit, follow-up 134 $126 $146
Office visit, established patient, complex (40-54 min) 131 $111 $162
Measurement of brain wave activity (eeg), 12-26 hours 91 $125 $200
Advance care planning consultation, first 30 min 86 $61 $108
Residence visit for new patient with moderate level of medical decision making, per day, if using time, at least 60 minutes 60 $100 $197
EEG, extended monitoring 57 $53 $600
Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique 55 $34 $50
Detection test by nucleic acid for cytomegalovirus (cmv), amplified probe technique 55 $34 $150
Detection test by nucleic acid for enterovirus (intestinal virus), amplified probe technique 55 $34 $50
Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique 55 $34 $45
Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique 55 $34 $45
Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets 55 $49 $50
Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique 55 $69 $75
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique 55 $34 $50
Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique 55 $34 $45
Infectious disease DNA/RNA test 55 $34 $45
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 55 $74 $100
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms 47 $195 $308
Residence visit for new patient with high level of medical decision making, per day, if using time, at least 75 minutes 43 $130 $213
Measurement of brain wave activity with video (veeg), 12-26 hours 35 $160 $220
Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional 32 $162 $220
Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment 29 $15 $40
Home visit, established patient, low complexity 25 $60 $140
Chronic care management, first 20 min/month 21 $49 $90
Transitional care management services for problem of high complexity 18 $194 $253
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit 14 $162 $165
Annual alcohol misuse screening, 5 to 15 minutes 14 $17 $37
Annual depression screening 12 $18 $40
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$200
Total received (2018-2024)
Avg $40/year across 5 years
Bottom 31% in TX for internal medicine
7
Companies
7
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$200 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$17
2023
$47
2022
$13
2019
$108
2018
$16

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Gilead Sciences, Inc.
$108
Neurelis, Inc.
$20
Amgen Inc.
$17
Novo Nordisk Inc
$16
Medtronic, Inc.
$14
Dexcom, Inc.
$13
Kowa Pharmaceuticals America, Inc.
$13
Top 3 companies account for 72.4% of total payments
Associated products mentioned in payments ›
Dexcom G6 Transmitter · INTELLIS ADAPTIVESTIM · Otezla · Seglentis · VALTOCO · Victoza
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1 per 100 Medicare services performed
Looking for an internal medicine specialist in Plano?
Compare internal medicine physicians in the Plano area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
2,127
Per 100K population
190.5
County median income
$117,588
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL PLANO
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Campbell is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Campbell experienced with drug screening test?
Based on Medicare claims data, Dr. Campbell performed 4,095 drug screening test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Campbell receive payments from pharmaceutical companies?
Yes. Dr. Campbell received a total of $200 from 7 companies across 7 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Campbell's costs compare to other internal medicine physicians in Plano?
Dr. Campbell's average Medicare payment per service is $101. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Campbell) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →